Concepedia

Maria Gerasimova

MG

Statistics

Publications

9

Citations

1.7K

H-Index

9

Active since

2011

Affiliations

VA San Diego Healthcare System(Current)

University of California San Diego

University of Würzburg

Lexicon Pharmaceuticals (United States)

Boehringer Ingelheim (Germany)

Maria Gerasimova is an author at VA San Diego Healthcare System specializing in renal pathophysiology, pharmacology, and medicine.

Publications per year

2011–2014

9

Publications

9

SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice

Volker Vallon, Maria Gerasimova, Michael Rose et al. · American Journal of Physiology-Renal Physiology · 2013 · 477 citations

, , +17

Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus

Volker Vallon, Michael Rose, Maria Gerasimova et al. · American Journal of Physiology-Renal Physiology · 2012 · 369 citations

, , +17

Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia

Timo Rieg, Takahiro Masuda, Maria Gerasimova et al. · American Journal of Physiology-Renal Physiology · 2013 · 303 citations

, , +16

Expression of Na<sup>+</sup>-<scp>d</scp>-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences

Ivan Sabolić, Ivana Vrhovac, Daniela Balen Eror et al. · American Journal of Physiology-Cell Physiology · 2012 · 194 citations · Full text

, , +16

Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice

Timo Rieg, Maria Gerasimova, Fiona Murray et al. · American Journal of Physiology-Renal Physiology · 2012 · 158 citations

, , +16

1–5 of 9